Resources

Recent Posts

• How Orenitram^® (treprostinil) Extended-Release Tablets May Help Lower Your Risk Status
• Clinical Trial of INOpulse Reduces Size, Results Expected Next Year
• I’m Still Learning the Importance of Self-advocacy When Living With a Rare Disease
• Aqualung Awarded $4.8M From NIH to Develop Monoclonal Antibody
• Fleeing Gun Violence With a Disability: An Unacceptable Sign of the Times